• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利新冠病毒变异株疫苗接种与传播的建模研究

A Modeling Study on Vaccination and Spread of SARS-CoV-2 Variants in Italy.

作者信息

Antonini Chiara, Calandrini Sara, Bianconi Fortunato

机构信息

ICT4life Srl, Via Mario Donati Guerrieri, 16, 06132 Perugia, Italy.

Department of Engineering, University of Perugia, Via Goffredo Duranti, 93, 06125 Perugia, Italy.

出版信息

Vaccines (Basel). 2021 Aug 17;9(8):915. doi: 10.3390/vaccines9080915.

DOI:10.3390/vaccines9080915
PMID:34452040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8402493/
Abstract

From the end of 2020, different vaccines against COVID-19 have been approved, offering a glimmer of hope and relief worldwide. However, in late 2020, new cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started to re-surge, worsened by the emergence of highly infectious variants. To study this scenario, we extend the Susceptible-Exposed-Infectious-Removed model with lockdown measures used in our previous work with the inclusion of new lineages and mass vaccination campaign. We estimate model parameters using the Bayesian method Conditional Robust Calibration in two case studies: Italy and the Umbria region, the Italian region being worse affected by the emergence of variants. We then use the model to explore the dynamics of COVID-19, given different vaccination paces and a policy of gradual reopening. Our findings confirm the higher reproduction number of Umbria and the increase of transmission parameters due to the presence of new variants. The results illustrate the importance of preserving population-wide interventions, especially during the beginning of vaccination. Finally, under the hypothesis of waning immunity, the predictions show that a seasonal vaccination with a constant rate would probably be necessary to control the epidemic.

摘要

从2020年底开始,多种针对2019冠状病毒病(COVID-19)的疫苗获得批准,给全球带来了一线希望和缓解。然而,在2020年末,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新病例开始再次激增,高传染性变种的出现使情况更加恶化。为了研究这种情况,我们扩展了之前工作中使用的带有封锁措施的易感-暴露-感染-康复模型,纳入了新的谱系和大规模疫苗接种活动。我们在意大利和翁布里亚地区这两个案例研究中,使用贝叶斯方法条件稳健校准来估计模型参数,意大利地区受变种出现的影响更为严重。然后,我们使用该模型来探索在不同疫苗接种速度和逐步重新开放政策下COVID-19的动态变化。我们的研究结果证实了翁布里亚地区较高的繁殖数以及由于新变种的存在导致传播参数的增加。结果表明了保持全人群干预措施的重要性,特别是在疫苗接种初期。最后,在免疫减弱的假设下,预测结果显示可能需要以恒定速率进行季节性疫苗接种来控制疫情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/97cde13e75d2/vaccines-09-00915-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/c52b120a69b0/vaccines-09-00915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/f485b3091d6c/vaccines-09-00915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/654cb1b2818e/vaccines-09-00915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/d411e9c06d72/vaccines-09-00915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/69004189e19e/vaccines-09-00915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/e3a40903af21/vaccines-09-00915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/51a5ce9385ca/vaccines-09-00915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/7ca89c392454/vaccines-09-00915-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/2461f588d47e/vaccines-09-00915-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/ea0ea20a178c/vaccines-09-00915-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/08e1e52c7e90/vaccines-09-00915-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/75f895c78e0b/vaccines-09-00915-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/8a9962dceb92/vaccines-09-00915-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/97cde13e75d2/vaccines-09-00915-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/c52b120a69b0/vaccines-09-00915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/f485b3091d6c/vaccines-09-00915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/654cb1b2818e/vaccines-09-00915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/d411e9c06d72/vaccines-09-00915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/69004189e19e/vaccines-09-00915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/e3a40903af21/vaccines-09-00915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/51a5ce9385ca/vaccines-09-00915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/7ca89c392454/vaccines-09-00915-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/2461f588d47e/vaccines-09-00915-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/ea0ea20a178c/vaccines-09-00915-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/08e1e52c7e90/vaccines-09-00915-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/75f895c78e0b/vaccines-09-00915-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/8a9962dceb92/vaccines-09-00915-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/8402493/97cde13e75d2/vaccines-09-00915-g014.jpg

相似文献

1
A Modeling Study on Vaccination and Spread of SARS-CoV-2 Variants in Italy.意大利新冠病毒变异株疫苗接种与传播的建模研究
Vaccines (Basel). 2021 Aug 17;9(8):915. doi: 10.3390/vaccines9080915.
2
Robustness analysis for quantitative assessment of vaccination effects and SARS-CoV-2 lineages in Italy.针对意大利疫苗接种效果和 SARS-CoV-2 谱系的定量评估的稳健性分析。
BMC Infect Dis. 2022 Apr 29;22(1):415. doi: 10.1186/s12879-022-07395-2.
3
Impacts of reopening strategies for COVID-19 epidemic: a modeling study in Piedmont region.新冠肺炎疫情重启策略的影响:皮埃蒙特大区的建模研究。
BMC Infect Dis. 2020 Oct 28;20(1):798. doi: 10.1186/s12879-020-05490-w.
4
Mathematical Modeling and Robustness Analysis to Unravel COVID-19 Transmission Dynamics: The Italy Case.用于揭示新冠病毒传播动态的数学建模与稳健性分析:意大利案例
Biology (Basel). 2020 Nov 11;9(11):394. doi: 10.3390/biology9110394.
5
Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy.意大利各地区的新冠疫情进展:北部地区将于 3 月底达到高峰,南部地区将于 4 月初达到高峰。
Int J Environ Res Public Health. 2020 Apr 27;17(9):3025. doi: 10.3390/ijerph17093025.
6
Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19.模拟新冠病毒变异株和疫苗对新冠疫情传播的影响。
Commun Nonlinear Sci Numer Simul. 2021 Nov;102:105937. doi: 10.1016/j.cnsns.2021.105937. Epub 2021 Jun 24.
7
SARS-CoV-2 Infection in Children in Southern Italy: A Descriptive Case Series.意大利南部儿童中 SARS-CoV-2 感染:一项描述性病例系列研究。
Int J Environ Res Public Health. 2020 Aug 21;17(17):6080. doi: 10.3390/ijerph17176080.
8
COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.使用改进的贝特曼易感-感染-恢复模型及德国海德堡观测数据进行的COVID-19大流行预测:接种SARS-CoV-2疫苗、冠状病毒检测及应用新冠警示应用程序的影响
Int J Clin Pharmacol Ther. 2020 Aug;58(8):417-425. doi: 10.5414/CP203846.
9
Epidemic Landscape and Forecasting of SARS-CoV-2 in India.印度 SARS-CoV-2 的疫情形势和预测。
J Epidemiol Glob Health. 2021 Mar;11(1):55-59. doi: 10.2991/jegh.k.200823.001. Epub 2020 Aug 28.
10
Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021.2021年8月美国各州对新冠病毒假定人群免疫力的估计。
Open Forum Infect Dis. 2022 Jan 17;9(2):ofab647. doi: 10.1093/ofid/ofab647. eCollection 2022 Feb.

引用本文的文献

1
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.预测 SARS-CoV-2 导致的健康结果的模型,包括疫苗接种的效果:系统评价。
Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1.
2
Sensitivity of endemic behaviour of COVID-19 under a multi-dose vaccination regime, to various biological parameters and control variables.在多剂量疫苗接种方案下,新冠病毒(COVID-19)地方流行行为对各种生物学参数和控制变量的敏感性。
R Soc Open Sci. 2023 May 10;10(5):221277. doi: 10.1098/rsos.221277. eCollection 2023 May.
3
Comparison of Clinical Features, Complete Blood Count Parameters, and Outcomes between Two Distinct Waves of COVID-19: A Monocentric Report from Italy.

本文引用的文献

1
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.自 2020 年 12 月 27 日至 2021 年 4 月中旬,意大利首剂 COVID-19 疫苗接种后不同时间间隔内 SARS-CoV-2 感染和随后住院及死亡的风险。
Euro Surveill. 2021 Jun;26(25). doi: 10.2807/1560-7917.ES.2021.26.25.2100507.
2
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.针对 SARS-CoV-2 的中和抗体反应在有症状的 COVID-19 中是持久的,对生存至关重要。
Nat Commun. 2021 May 11;12(1):2670. doi: 10.1038/s41467-021-22958-8.
3
两波不同的新冠疫情临床特征、全血细胞计数参数及结局比较:来自意大利的单中心报告
Healthcare (Basel). 2022 Nov 30;10(12):2427. doi: 10.3390/healthcare10122427.
4
Robustness analysis for quantitative assessment of vaccination effects and SARS-CoV-2 lineages in Italy.针对意大利疫苗接种效果和 SARS-CoV-2 谱系的定量评估的稳健性分析。
BMC Infect Dis. 2022 Apr 29;22(1):415. doi: 10.1186/s12879-022-07395-2.
5
What Happens to the Immune System after Vaccination or Recovery from COVID-19?接种疫苗或从新冠病毒感染中康复后免疫系统会发生什么?
Life (Basel). 2021 Oct 29;11(11):1152. doi: 10.3390/life11111152.
Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系B.1.1.7和P.1在意大利的出现与传播。
Viruses. 2021 Apr 29;13(5):794. doi: 10.3390/v13050794.
4
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.单剂 Ad26.COV2.S 疫苗预防新冠病毒的安全性和有效性。
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
5
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.意大利疫苗接种推广、新冠病毒变异株及非药物干预措施需求的建模
Nat Med. 2021 Jun;27(6):993-998. doi: 10.1038/s41591-021-01334-5. Epub 2021 Apr 16.
6
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.巴西玛瑙斯市 P.1 型 SARS-CoV-2 谱系的基因组学和流行病学研究。
Science. 2021 May 21;372(6544):815-821. doi: 10.1126/science.abh2644. Epub 2021 Apr 14.
7
SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.意大利第一波和第二波 COVID-19 期间 SARS-CoV-2 感染发生率。
Environ Res. 2021 Jun;197:111097. doi: 10.1016/j.envres.2021.111097. Epub 2021 Apr 1.
8
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.BNT162b2 疫苗和 mRNA-1273 新冠疫苗在预防医护人员、第一响应者和其他必要及一线工作人员感染 SARS-CoV-2 中的疫苗有效性的临时估计-2020 年 12 月至 2021 年 3 月美国 8 个地点。
MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3.
9
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.2019冠状病毒病的疫苗接种与非药物干预措施:一项数学建模研究
Lancet Infect Dis. 2021 Jun;21(6):793-802. doi: 10.1016/S1473-3099(21)00143-2. Epub 2021 Mar 18.
10
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.